SCHEMBL21035294

SCHEMBL21035294

c1ccc2c(c1)sc1cccc(-c3cccc4c(-c5ccc6c(c5)c5ccccc5c5c7ccccc7c7ccccc7c65)cccc34)c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.41
BRDT Q58F21 1/20 0.39
F9 P00740 1/20 0.38
GPR3 P46089 1/20 0.38
MAPT P10636 5/20 0.37
ALDH1A1 P00352 4/20 0.37
HPGD P15428 4/20 0.37
RAB9A P51151 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TSHR P16473 2/20 0.34
MAPK1 P28482 2/20 0.34
HSD17B10 Q99714 2/20 0.34
CASP1 P29466 1/20 0.34
HIF1A Q16665 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34
KDM4E B2RXH2 1/20 0.33
S1PR4 O95977 2/20 0.33
S1PR5 Q9H228 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21036056 0.98 ALOX5 (0.40) ALOX5BRDTF9GPR3MAPT
SCHEMBL21036057 0.94 F9 (0.41) ALOX5BRDTF9GPR3MAPT
SCHEMBL21036048 0.94 ALOX5 (0.43) ALOX5BRDTF9GPR3MAPT
SCHEMBL21036047 0.94 ALOX5 (0.43) ALOX5BRDTF9GPR3MAPT
SCHEMBL21036060 0.93 F9 (0.40) ALOX5BRDTF9GPR3MAPT
SCHEMBL17229085 0.91 ALOX5 (0.43) ALOX5BRDTF9GPR3MAPT
SCHEMBL22789818 0.91 ALOX5 (0.45) ALOX5BRDTF9GPR3MAPT
SCHEMBL12175626 0.91 ALOX5 (0.45) ALOX5BRDTF9GPR3MAPT
SCHEMBL25081653 0.90 ALOX5 (0.40) ALOX5BRDTF9GPR3MAPT
SCHEMBL21036049 0.88 F9 (0.40) ALOX5BRDTF9GPR3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190165279-A1 ORGANIC ELECTROLUMINESCENT ELEMENT JNC CORPORATION (JP) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190165279-A1 ORGANIC ELECTROLUMINESCENT ELEMENT TCF4, LGR4, OR51E2 ALOX5 2414/4885BRDT 1244/4885F9 2520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.